{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:08:01Z","timestamp":1778803681693,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H06177"],"award-info":[{"award-number":["JP17H06177"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H02810"],"award-info":[{"award-number":["JP22H02810"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19J23608"],"award-info":[{"award-number":["JP19J23608"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06165"],"award-info":[{"award-number":["JP23K06165"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JPMJSP2127"],"award-info":[{"award-number":["JPMJSP2127"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22bm0804013h0006"],"award-info":[{"award-number":["22bm0804013h0006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ek0310017h0003"],"award-info":[{"award-number":["23ek0310017h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004091","name":"Kumamoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jphs.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:44:43Z","timestamp":1768549483000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome"],"prefix":"10.1016","volume":"160","author":[{"given":"Aimi","family":"Owaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Kaseda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Miike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sannomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Tsuhako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Horizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Tokuyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Takeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishinakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2026.01.005_bib1","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, Goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jphs.2026.01.005_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib3","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2026.01.005_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-016-3452-z","article-title":"Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations","volume":"32","author":"Stock","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2026.01.005_bib7","series-title":"Alport syndrome","author":"Nozu","year":"1993"},{"key":"10.1016\/j.jphs.2026.01.005_bib8","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1038\/s41598-021-86109-1","article-title":"Metformin ameliorates the severity of experimental Alport syndrome","volume":"11","author":"Omachi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2026.01.005_bib9","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202503330","article-title":"Efficacy of Nrf2 activation in a proteinuric Alport syndrome mouse model","volume":"8","author":"Kaseda","year":"2025","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jphs.2026.01.005_bib10","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib11","article-title":"Role of TL1A in inflammatory autoimmune diseases: a comprehensive review","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jphs.2026.01.005_bib12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.kint.2020.05.029","article-title":"Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome","volume":"98","author":"Jia","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jphs.2026.01.005_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.jphs.2026.01.005_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jphs.2025.09.008","article-title":"Dapagliflozin with losartan but not olmesartan has an add-on protective effect in experimental Alport syndrome","volume":"159","author":"Horizono","year":"2025","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jphs.2026.01.005_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.34067\/KID.0004572021","article-title":"Novel Keap1-Nrf2 protein-protein interaction inhibitor UBE-1099 ameliorates progressive phenotype in Alport syndrome mouse model","volume":"3","author":"Kaseda","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.jphs.2026.01.005_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10157-017-1386-9","article-title":"Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model","volume":"21","author":"Omachi","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/ndt\/gfx246","article-title":"STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model","volume":"33","author":"Yokota","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jphs.2026.01.005_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1681\/ASN.2014111109","article-title":"Podocyte p53 limits the severity of experimental Alport syndrome","volume":"27","author":"Fukuda","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jphs.2026.01.005_bib20","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2026.01.005_bib21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2026.01.005_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jphs.2026.01.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119233","article-title":"Effects of circular RNA Ttc3\/miR-148a\/Rcan2 axis on inflammation and oxidative stress in rats with acute kidney injury induced by sepsis","volume":"272","author":"Ma","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2026.01.005_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/15513815.2023.2239904","article-title":"Expression of GADD45B in renal tissue of children with IgA nephropathy and correlation with mesangial hypercellularity","volume":"42","author":"Li","year":"2023","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.jphs.2026.01.005_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.300","article-title":"GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway","volume":"7","author":"Chen","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jphs.2026.01.005_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/DMSO.S238138","article-title":"Egr1 knockdown combined with an ACE inhibitor ameliorates diabetic kidney disease in mice: blockade of compensatory renin increase","volume":"13","author":"Hu","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jphs.2026.01.005_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3405695","article-title":"Early growth response 1 (Egr1) is a transcriptional activator of NOX4 in oxidative stress of diabetic kidney disease","volume":"2018","author":"Hu","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jphs.2026.01.005_bib28","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/s12276-024-01319-7","article-title":"Unveiling the role of transgelin as a prognostic and therapeutic target in kidney fibrosis via a proteomic approach","volume":"56","author":"Kwon","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jphs.2026.01.005_bib29","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep4.1866","article-title":"TGF\u03b2-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer","volume":"6","author":"B\u00e9vant","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jphs.2026.01.005_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2011\/940827","article-title":"NF-kB expression in IgA nephropathy outcome","volume":"31","author":"Silva","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.jphs.2026.01.005_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/FJC.0000000000001268","article-title":"Dapagliflozin attenuates contrast-induced acute kidney injury by regulating the HIF-1\u03b1\/HE4\/NF-\u03baB pathway","volume":"79","author":"Huang","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2026.01.005_bib32","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s11255-017-1622-y","article-title":"Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of rho GTPases","volume":"49","author":"Dong","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jphs.2026.01.005_bib33","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.4049\/jimmunol.1301475","article-title":"TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses","volume":"191","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jphs.2026.01.005_bib34","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202012776","article-title":"Caldesmon ablation in mice causes umbilical herniation and alters contractility of fetal urinary bladder smooth muscle","volume":"153","author":"P\u00fctz","year":"2021","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jphs.2026.01.005_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/genes13101893","article-title":"A comparative presentation of mouse models that recapitulate most features of Alport syndrome","volume":"13","author":"Nikolaou","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.jphs.2026.01.005_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126674","article-title":"Col4a3(-\/-) mice on Balb\/C background have less severe cardiorespiratory phenotype and SGLT2 over-expression compared to 129x1\/SvJ and C57Bl\/6 backgrounds","volume":"23","author":"Irion","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2026.01.005_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161802","article-title":"X-linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations","volume":"11","author":"Savige","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2026.01.005_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1620\/tjem.2023.J060","article-title":"X-linked Alport syndrome with type IV collagen \u03b15 chain staining revealing normal expression in the glomerular basement membrane and negative on Bowman's capsule and distal tubular basement membrane: a case report","volume":"261","author":"Okamoto","year":"2023","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jphs.2026.01.005_bib39","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0002-9440(10)64802-X","article-title":"Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy","volume":"157","author":"Cosgrove","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jphs.2026.01.005_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099083","article-title":"Laminin \u03b12-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis","volume":"9","author":"Delimont","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2026.01.005_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cyto.2013.04.004","article-title":"Multiple activating and repressive cis-promoter regions regulate TNFSF15 expression in human primary mononuclear cells","volume":"63","author":"Gonsky","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jphs.2026.01.005_bib42","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ajpath.2012.01.003","article-title":"DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor","volume":"180","author":"Al-Lamki","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jphs.2026.01.005_bib43","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jphs.2026.01.005_bib44","article-title":"The role of macrophages in kidney fibrosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jphs.2026.01.005_bib45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI39569","article-title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome","volume":"120","author":"Tanaka","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jphs.2026.01.005_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2369-15-178","article-title":"TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells","volume":"15","author":"Wang","year":"2014","journal-title":"BMC Nephrol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:14:01Z","timestamp":1778800441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861326000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1347861326000058"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2026.01.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}